Systemic sclerosis [scleroderma] Notes: Combination of calcinosis, Raynaud’s phenomenon, esophageal dysfunction, sclerodactyly, telangiectasia ; code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) ; circumscribed scleroderma (L94.0) ; neonatal scleroderma (P83.88) ; poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4 or 6)
Post COVID-19 condition, unspecified Notes: Post-acute sequela of COVID-19 ; the specific condition related to…
Post COVID-19 condition Notes: Post-acute sequela of COVID-19 ; the specific condition related to COVID-19…
COVID-19 Notes: code to identify pneumonia or other manifestations, such as: ; pneumonia due to…
Vaping-related disorder Notes: Dabbing related lung damage ; Dabbing related lung injury ; E-cigarette, or…
Emergency use of U07 Notes: Dabbing related lung damage ; Dabbing related lung injury ;…
Dependence on other enabling machines and devices Notes: Dependence on machine or device NOS